Literature DB >> 477612

Comparison of human calcitonin secretion after a 1-minute calcium infusion in young normal and in elderly subjects.

S Morimoto, T Onishi, Y Okada, K Tanaka, M Tsuji, Y Kumahara.   

Abstract

Human calcitonin (hCT) response to a 1-minute calcium infusion was studied in 6 male and 4 female young normal subjects and in 6 male and 6 female elderly subjects. In the young subjects plasma hCT levels increased significantly (p less than 0.01) from mean basal value of 82.3 +/- 48.7 pg/ml to maximum level of 407.5 +/-198.0 pg/ml in the male, while it increased from 96.3 +/- 89.2 to 216.3 +/- 89.1 pg/ml p less than 0.05) in the female. In the elderly subjects, it increased from 80.3 +/- 56.9 pg/ml to maximum level of 229.2 +/- 130.6 pg/ml (p less than 0.05) in the male, while it increased from 109.2 +/- 43.7 to 163.3 +/- 55.7 pg/ml (p less than 0.005) in the female. There was no significant difference in the basal hCT level of these 4 groups. In both the young and the elderly, however, mean increment of hCT level was significantly (p less than 0.05) higher in the male than in the female of the same-aged group. In both the female and the male subjects, it was significantly (p less than 0.05) higher in the young than in the elderly of the same sex. A 1-minute infusion of calcium can be used as a reliable provocative test for hCT secretion in human subjects.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477612     DOI: 10.1507/endocrj1954.26.207

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  8 in total

1.  Absence of evidence for a role of calcitonin in the etiology of femoral neck fracture.

Authors:  T R Beringer; J Ardill; H M Taggart
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

2.  Racial differences in calcitonin and katacalcin.

Authors:  J C Stevenson; C H Myers; A B Ajdukiewicz
Journal:  Calcif Tissue Int       Date:  1984-12       Impact factor: 4.333

3.  Calcitonin secretion in streak gonad syndrome (Turner's syndrome).

Authors:  J Zseli; P Bosze; F Szalay; J Szucs; C Horvath; E Kollin; M Szathmari; J Laszlo; I Hollo
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

4.  Safety of calcitonin stimulation tests with calcium.

Authors:  Mara Băetu; Cristina Alexandra Olariu; Ileana Nițu; Gabriel Moldoveanu; Cristina Corneci; Corin Badiu
Journal:  Hormones (Athens)       Date:  2021-09-01       Impact factor: 2.885

5.  Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females.

Authors:  S Nakamura; S Morimoto; S Takamoto; T Onishi; K Fukuo; E Koh; S Kitano; Y Miyashita; O Yasuda; M Tamatani
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

6.  1,25(OH)2D and 24,25(OH)2D production in the developing kidney.

Authors:  M Ishida; M Shima; Y Seino
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

7.  Serum calcitonin forms and concentrations in young and elderly healthy females.

Authors:  E Bucht; H Rong; H E Sjöberg; U Sjöstedt; B Granberg; O Tørring
Journal:  Calcif Tissue Int       Date:  1995-01       Impact factor: 4.333

8.  Serum calcium regulating hormones in the perinatal period.

Authors:  Y Seino; M Ishida; K Yamaoka; T Ishii; T Hiejima; C Ikehara; Y Tanaka; S Matsuda; T Shimotsuji; H Yabuuchi; S Morimoto; T Onishi
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.